In a preclinical setting, tumor mass and the degree of angiogenesis in intrapleural tumors were reduced when PAI-1 inhibitor was administered to mice in which MPM cells expressing high levels of VEGF (VEGF-A) which were intrapleurally transplanted (174). The gene discussed is SERPINE1; the disease is neoplasm.